{"schema_version":"1","generated_at":"2026-11-06T04:13:49.554Z","data_as_of":null,"url":"https://www.findmykol.com/kol/lisa-niswander","json_url":"https://www.findmykol.com/kol/lisa-niswander/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"lisa-niswander","name":"Lisa Niswander","credential":"MD, PhD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Roswell Park Comprehensive Cancer Center","institution_url":"https://www.findmykol.com/institution/roswell-park-comprehensive-cancer-center","city":"Buffalo","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1669821443","orcid":"0000-0003-3608-7649","openalex":"A5012235709"},"summary":"Lisa Niswander is an Oncology physician affiliated with Roswell Park Comprehensive Cancer Center. OpenAlex indexes 32 publications with 656 citations (h-index 12).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":32,"cited_by_count":656,"h_index":12,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"JAZZ PHARMACEUTICALS INC.","program_year":2024,"amount_usd":143.43,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1669821443"},{"payer":"Jazz Pharmaceuticals Inc.","program_year":2023,"amount_usd":99.55,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1669821443"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1669821443","source":"payments"},"funding":{"award_count":2,"fiscal_years":{"first":2013,"last":2026},"rows_total":6,"shown":3,"withheld":3,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K08CA286765","title":"Leveraging small molecule inhibitors to improve CD19 CAR T cell immunotherapy for KMT2A-rearranged ALL","fiscal_year":2026,"amount_usd":"196110","organization":"ROSWELL PARK CANCER INSTITUTE CORP","source_url":"https://reporter.nih.gov/quickSearch/K08CA286765"},{"project":"K08CA286765","title":"Leveraging small molecule inhibitors to improve CD19 CAR T cell immunotherapy for KMT2A-rearranged ALL","fiscal_year":2025,"amount_usd":"196110","organization":"ROSWELL PARK CANCER INSTITUTE CORP","source_url":"https://reporter.nih.gov/quickSearch/K08CA286765"},{"project":"K08CA286765","title":"Leveraging small molecule inhibitors to improve CD19 CAR T cell immunotherapy for KMT2A-rearranged ALL","fiscal_year":2024,"amount_usd":"172190","organization":"ROSWELL PARK CANCER INSTITUTE CORP","source_url":"https://reporter.nih.gov/quickSearch/K08CA286765"}],"source":"grants"},"publications":{"total":32,"shown":5,"withheld":27,"matched_by":"OpenAlex author record","recent":[{"title":"The Use of Targeted Therapy in Pediatric Acute Lymphoblastic Leukemia: Exploring Novel Approaches and Emerging Therapies","year":2026,"journal":"Current Treatment Options in Oncology","source_url":"https://doi.org/10.1007/s11864-025-01376-8","status":"verified"},{"title":"Abstract 1558: Preclinical activity of ziftomenib and CAR T cell immunotherapy in KMT2A -rearranged (R) acute leukemias","year":2026,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2026-1558","status":"verified"},{"title":"Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia","year":2024,"journal":"Leukemia","source_url":"https://doi.org/10.1038/s41375-024-02493-3","status":"verified"},{"title":"Gilteritinib Augments Preclinical FLT3 and CD19 CAR T Cell Immunotherapy in High-Risk Pediatric Leukemias","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-206467","status":"verified"},{"title":"Co-Targeting of the Thymic Stromal Lymphopoietin Receptor to Decrease Immunotherapeutic Resistance in CRLF2-Rearranged Ph-like and Down Syndrome ALL","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-208383","status":"verified"}],"source":"works"},"contact":{"address_1":"ELM AND CARLTON ST","city":"Buffalo","state":"NY","zip":"142630001","phone":"716-845-2300","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1669821443","source":"identity"},"similar":[{"name":"Igor Puzanov","slug":"igor-puzanov","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/igor-puzanov","json_url":"https://www.findmykol.com/kol/igor-puzanov/profile.json"},{"name":"Philip McCarthy","slug":"philip-mccarthy","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/philip-mccarthy","json_url":"https://www.findmykol.com/kol/philip-mccarthy/profile.json"},{"name":"Saby George","slug":"saby-george","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/saby-george","json_url":"https://www.findmykol.com/kol/saby-george/profile.json"},{"name":"Eunice Wang","slug":"eunice-wang","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/eunice-wang","json_url":"https://www.findmykol.com/kol/eunice-wang/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":3,"publications":27}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-07-01","provider_certified":"2024-07-01","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}